Search

Your search keyword '"Rangel-Sousa, Diego"' showing total 6 results
Start Over Author "Rangel-Sousa, Diego" Publication Year Range This year
6 results on '"Rangel-Sousa, Diego"'

1. Repetitive ambulatory levosimendan as a bridge to heart transplantation

Author

de Juan Bagudá, Javier, de Frutos, Fernando, López-Vilella, Raquel, Couto Mallón, David, Guzman-Bofarull, Joan, Blazquez-Bermejo, Zorba, Cobo-Belaustegui, Manuel, Mitroi, Cristina, Pastor-Pérez, Francisco J., Moliner-Abós, Carlos, Rangel-Sousa, Diego, Díaz-Molina, Beatriz, Tobar-Ruiz, Javier, Salterain Gonzalez, Nahikari, García-Pinilla, José Manuel, García-Cosío Carmena, María Dolores, Crespo-Leiro, María Generosa, Dobarro, David, Almenar, Luis, Delgado-Jiménez, Juan F., Paredes-Galán, Emilio, González-Vílchez, Francisco, and González-Costello, José

Published
2024
Full Text
View/download PDF

2. Levosimendán ambulatorio repetitivo como puente al trasplante cardiaco

Author

de Juan Bagudá, Javier, de Frutos, Fernando, López-Vilella, Raquel, Couto Mallón, David, Guzman-Bofarull, Joan, Blazquez-Bermejo, Zorba, Cobo-Belaustegui, Manuel, Mitroi, Cristina, Pastor-Pérez, Francisco J., Moliner-Abós, Carlos, Rangel-Sousa, Diego, Díaz-Molina, Beatriz, Tobar-Ruiz, Javier, Salterain Gonzalez, Nahikari, García-Pinilla, José Manuel, García-Cosío Carmena, María Dolores, Crespo-Leiro, María Generosa, Dobarro, David, Almenar, Luis, Delgado-Jiménez, Juan F., Paredes-Galán, Emilio, González-Vílchez, Francisco, and González-Costello, José

Published
2024
Full Text
View/download PDF

3. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant

Author

Cabezón-Villalba, Gonzalo, Barge-Caballero, Eduardo, González-Vílchez, Francisco, Castel-Lavilla, María Ángeles, Gómez-Bueno, Manuel, Almenar-Bonet, Luis, González-Costello, José, Lambert-Rodríguez, José Luis, Martínez-Sellés, Manuel, de la Fuente-Galán, Luis, Mirabet-Pérez, Sonia, García-Cosío Carmena, María Dolores, Hervás-Sotomayor, Daniela, Rangel-Sousa, Diego, Blasco-Peiró, Teresa, Garrido-Bravo, Iris P., Rábago Juan-Aracil, Gregorio, Muñiz, Javier, and Crespo-Leiro, María G.

Published
2024
Full Text
View/download PDF

4. Uso de un sistema extracorpóreo de asistencia circulatoria de flujo continuo, corta duración e inserción quirúrgica como puente a trasplante

Author

Cabezón-Villalba, Gonzalo, Barge-Caballero, Eduardo, González-Vílchez, Francisco, Castel-Lavilla, María Ángeles, Gómez-Bueno, Manuel, Almenar-Bonet, Luis, González-Costello, José, Lambert-Rodríguez, José Luis, Martínez-Sellés, Manuel, de la Fuente-Galán, Luis, Mirabet-Pérez, Sonia, García-Cosío Carmena, María Dolores, Hervás-Sotomayor, Daniela, Rangel-Sousa, Diego, Blasco-Peiró, Teresa, Garrido-Bravo, Iris P., Rábago Juan-Aracil, Gregorio, Muñiz, Javier, and Crespo-Leiro, María G.

Published
2024
Full Text
View/download PDF

5. Trasplante cardiaco en paciente portador de Berlin Heart EXCOR®, con rechazo agudo refractario a tratamiento corticoideo: un reto diagnóstico

Author

Pérez-Gómez, Laura, Esteve-Ruiz, Iris María, Campos-Pareja, Ana María, and Rangel-Sousa, Diego

Abstract

Se presenta el caso de una paciente de 55 años con insuficiencia cardiaca severa, secundaria a miocarditis, con fracción de eyección severamente deprimida, remitida a nuestro hospital para valoración pretrasplante cardiaco. Debido a la presencia de resistencias vasculares pulmonares elevadas, a pesar de la optimización del tratamiento médico vasodilatador, se decide implantar un EXCOR®como puente al trasplante. Con el presente artículo pretendemos revindicar la importancia de los dispositivos de asistencia ventricular de larga duración, para solventar la contraindicación que supone la hipertensión pulmonar severa en el trasplante cardiaco. Además, nuestra paciente presentó las 2 complicaciones de etiología inmunológica más frecuentes que pueden surgir a corto-medio plazo, exponiendo en el caso clínico las diferentes técnicas diagnósticas y las opciones de tratamiento disponibles para hacer frente al rechazo tanto humoral como celular hacia el órgano trasplantado.

Published
2024
Full Text
View/download PDF

6. Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study.

Author

Blasco-Turrión S, Crespo-Leiro MG, Donoso Trenado V, Chi Hion PL, Díaz Molina B, Roura G, Álvarez-Osorio MP, Gómez-Bueno M, Ortiz Bautista C, Diaz JF, Garrido Bravo IP, Moreno R, Sarnago-Cebada F, Salterain González N, de la Torre Hernandez JM, García Del Blanco B, Farrero M, Ortas Nadal R, Martin P, de La Fuente L, Sanz-Sánchez J, Mirabet Pérez S, Alonso Fernández V, Gómez Hospital JA, López Granados A, Couto-Mallon D, Del Trigo Espinosa M, Rangel Sousa D, Zatarain-Nicolás E, Arzamendi Aizpurua D, López Vilella R, San Román JA, and Amat-Santos IJ

Abstract

Background: The current incidence and outcomes of structural transcatheter procedures in heart transplant (HTx) recipients and left-ventricular assist devices (LVAD) carriers is unknown., Aims: To provide insights on structural transcatheter procedures performed across HTx and LVAD patients in Spain., Methods: Multicenter, ambispective, observational nationwide registry., Results: Until May/2023, 36 percutaneous structural interventions were performed (78% for HTx and 22% for LVAD) widely varying among centers (0%-1.4% and 0%-25%, respectively). Percutaneous mitral transcatheter edge-to-edge (TEER) was the most common (n = 12, 33.3%), followed by trancatheter aortic valve replacement (n = 11, 30.5%), and tricuspid procedures (n = 9, 25%). Mitral TEER resulted in mild residual mitral regurgitation in all but one case, mean gradient was <5 mmHg in 75% of them at 1-year, with no mortality and 8.3% re-admission rate. Tricuspid TEER resulted in 100% none/mild residual regurgitation with a 1-year mortality and readmission rates of 22% and 28.5%, respectively. Finally, trancatheter aortic valve replacement procedures (n = 8 in LVADs due to aortic regurgitation and n = 3 in HTx), were successful in all cases with one prosthesis degeneration leading to severe aortic regurgitation at 1-year, 18.2% mortality rate and no re-admissions. Globally, major bleeding rates were 7.9% and 12.5%, thromboembolic events 3.7% and 12.5%, readmissions 37% and 25%, and mortality 22% and 25%, in HTx and LVADs respectively. No death was related to the implanted transcatheter device., Conclusions: Most centers with HTx/LVAD programs perform structural percutaneous procedures but with very inconsistent incidence. They were associated with good safety and efficacy, but larger studies are required to provide formal recommendations., Competing Interests: Declaration of competing interest None., (Copyright © 2024 Elsevier B.V. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results